background image
RESEARCH DIRECTORY
Dr. Schleien researches
cardiopulmonary
resuscitation, including
brain-blood flow, drug effects,
metabolism and mechanics
of CPR. Recently, his focus
has been in pediatric CPR
and hypothermia following
cardiac arrest in children. He
also has an interest in clinical
bioethics in children, as well
as other critical care topics.
Dr. Schulder investigates
new methods of image
guidance for neurosurgery,
including the incorporation
of functional MRI as well as
intraoperative MRI.
Dr. Shafritz's research
examines the neural and
cognitive mechanisms of
attention, executive function
and emotion. He also studies
psychological disorders
that involve dysregulation
of these processes, such as
autism and attention deficit
hyperactivity disorder. He
works to determine the brain
mechanisms underlying
behavioral disorders so that
future treatments can target
those specific brain areas.
Dr. Schanler researches
neonatal nutrition and critical
inflammatory disorders of
newborns. His nutritional and
anti-inflammatory studies aim
to provide better outcomes
for infants in the neonatal
intensive care unit.
Dr. Sherry's research interest
is in the mechanisms that
coordinate the innate immune
response. Her ultimate goal is
to gain a better understanding
of the molecular mechanisms
that regulate chemokine
and chemokine receptor
responses in healthy
individuals, and to identify
how these pathways are
dysregulated in sepsis,
HIV infection and chronic
lymphocytic leukemia.
CHARLES SCHLEIEN, MD
Patient-Oriented Research
MICHAEL SCHULDER, MD
Neuroscience
KEITH M. SHAFRITZ, PHD
Psychiatric Neuroscience
RICHARD J. SCHANLER, MD
Immunology & Inflammation
BARBARA SHERRY, PHD
Immunology & Inflammation
Dr. Silverman researches
pre-diabetes and diabetes in
emergency room patients,
as well as the effects of air
pollution on asthma-related
hospital admissions. He also
studies air pollution and
cardiac deaths that occur
outside of the hospital.
Dr. Simpkins uses si/sh RNA
knockdown techniques
to study the molecular
mechanisms of cisplatin
resistance that develops in
tumor cells. He is studying
his area of medicine to
create safer, more effective
chemotherapies.
Dr. Singh is focused on
elucidating the pathways
responsible for the cancer
predisposition in patients
with bone marrow failure
syndromes. A recent research
focus is on determining the
impact of ribosomal protein
haploin sufficiency on the
immune system.
ROBERT A. SILVERMAN, MD
Patient-Oriented Research
HENRY SIMPKINS, MD, PHD
Patient-Oriented Research
SHARON SINGH, MD
Oncology & Cell Biology
31
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH